MTHFD2-Mediated Ubiquitination and Degradation of FOXO1 Promote Tongue Squamous Cell Carcinoma Progression
- 19 November 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 24 (4) , 270-282
Abstract
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2), a pivotal enzyme in one-carbon metabolism, is significantly overexpressed in tongue squamous cell carcinoma (TSCC) and correlates with poor patient prognosis. Functional studies demonstrate that MTHFD2 drives TSCC proliferation and migration in vitro and in vivo, whereas its inhibition suppresses tumor progression. Mechanistically, MTHFD2 orchestrates a dual posttranslational modification cascade: Through its enzymatic activity, it simultaneously induces forkhead box O1 (FOXO1) hypermethylation and ubiquitination, ultimately triggering ubiquitin–proteasome degradation of this tumor suppressor. This methylation-primed degradation axis is clinically validated by the inverse MTHFD2-high/FOXO1-low expression pattern in TSCC specimens, which predicts adverse outcomes. Critically, pharmacologic inhibition of MTHFD2 (e.g., DS18561882) blocks FOXO1 degradation, establishing the MTHFD2–FOXO1 axis as a promising therapeutic target for TSCC through its novel metabolic–epigenetic regulatory mechanism. Implications: This study identifies the MTHFD2–FOXO1 axis as a druggable metabolic–epigenetic pathway in TSCC, providing both a prognostic marker and a therapeutic target.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82071033)
- National Natural Science Foundation of China (82371135)
- Key Research and Development Project of Hubei Province (2022BCA040)
This publication has 38 references indexed in Scilit:
- SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinomaCellular Oncology, 2023
- Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathwayBiomedicine & Pharmacotherapy, 2023
- FOXO transcription factors as therapeutic targets in human diseasesTrends in Pharmacological Sciences, 2022
- Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastomaCancer Letters, 2022
- Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathwayBiochemical and Biophysical Research Communications, 2022
- Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapyDrug Discovery Today, 2021
- Comparison of nomogram with machine learning techniques for prediction of overall survival in patients with tongue cancerInternational Journal of Medical Informatics, 2021
- Forkhead Transcription Factors: Key Players in Development and MetabolismDevelopmental Biology, 2002
- Cloning and Characterization of Three Human Forkhead Genes That Comprise an FKHR-like Gene SubfamilyGenomics, 1998
- Occurrence of a DPN-linked, N5,N10-methylene tetrahydrofolic dehydrogenase in Ehrlich ascites tumor cellsBiochemical and Biophysical Research Communications, 1960